Search - tctmd.com

Displaying 81 - 100 of 159

Sort: Relevancy | Date

News Daily News

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

October 16, 2013

News Daily News

Postconditioning Ineffective in STEMI Patients Receiving Primary PCI

Caitlin E. Cox

September 27, 2013

News Daily News

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

L.A. McKeown

August 19, 2013

News Daily News

Effect of PCI-Related Bleeding on Mortality Risk Varies by Location

Caitlin E. Cox

August 05, 2013

News Daily News

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

L.A. McKeown

July 24, 2013

News Daily News

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

Leah Lawrence

July 11, 2013

News Conference News EuroPCR 2013

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Caitlin E. Cox

May 29, 2013

News Conference News EuroPCR 2013

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

Yael L. Maxwell

May 23, 2013

News Daily News

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Caitlin E. Cox

May 03, 2013

News Daily News

Bleeding Tied to Increased In-Hospital Mortality in Large PCI Registry

March 15, 2013

News Conference News ACC 2013

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

Caitlin E. Cox

March 12, 2013

News Daily News

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

February 27, 2013

News Daily News

Unknowns Predominate in Variable Clopidogrel Response

January 16, 2013

News Daily News

State Registry Shows Radial PCI Rare but Beneficial

January 14, 2013

News Daily News

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

L.A. McKeown

January 06, 2013

News Daily News

Meta-analysis Questions Safety of Routine Blood Transfusion for AMI Patients

December 27, 2012

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

Presentation TCT 2012

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Presenter: Rajesh Dave

October 25, 2012

$Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!$

Presentation TCT 2012

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Presenter: Gilles Montalescot

October 25, 2012

Advertisement

Hypothermia Does Not Increase Stent Thrombosis Risk in Primary PCI Patients

Postconditioning Ineffective in STEMI Patients Receiving Primary PCI

Radial PCI Plus Bivalirudin Effective in Lowering Bleeding Risk

Effect of PCI-Related Bleeding on Mortality Risk Varies by Location

Comparison of Therapies in Multivessel CAD Finds Similar LVEF Preservation at 10 Years

HORIZONS-AMI: Bivalirudin, Taxus Improve Outcomes in LAD PCI Patients

EuroPCR 2013: From Cutting-Edge Devices to the Clinical Challenges

Registry Questions Superiority of Bivalirudin Over Heparin Alone in NSTE-ACS

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Bleeding Tied to Increased In-Hospital Mortality in Large PCI Registry

SELECT-ACS: Novel Drug Limits Myocardial Damage After PCI for NSTEMI

AIDA STEMI Substudy Confirms No Advantage for Intracoronary Abciximab

Unknowns Predominate in Variable Clopidogrel Response

State Registry Shows Radial PCI Rare but Beneficial

JACC Letter: Hypothermia Therapy May Increase Stent Thrombosis Risk

Meta-analysis Questions Safety of Routine Blood Transfusion for AMI Patients

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Glycoprotein IIb/IIIa Inhibitors in the Era of Bivalirudin and New Oral Antiplatelet Agents: Is Intracoronary Application the Standard of Choice?

Debate: Enoxaparin or Unfractionated Heparin Plus/Minus Glycoprotein IIb/IIIa Inhibitors Is the Preferred Anticoagulant Strategy During STEMI!

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content